Sohail G Contractor, MD
Interventional Radiology · Louisville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 8
Offices
8 locations · University of Louisville Physicians Inc · Bowling Green-Warren County Community Hospital Corporation · Baptist Health Medical Group Inc · Meritus Medical Center Inc
Hospitals listed: Meritus Medical Center · University of Louisville Hospital · Uofl Health - Jewish Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Contractor’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- New Jersey 25MA06629600Medical Doctor · since 1997 · expires 2021-06-30InactiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Meritus Medical CenterHagerstown, MDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Meritus HealthPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.2 (11.5 to 17.6) · 314 cases, Jan 2024 – Dec 2024Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.9 (1.6 to 2.3) · 630 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.268, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.207, Oct 2024 – Sep 2025
- University of Louisville HospitalLouisville, KYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of UofL Health, which runs 7 hospitalsPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 221.77 (180.78 to 262.76) · 121 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.362, Oct 2024 – Sep 2025
- Uofl Health - Jewish Hospital and Mary & Elizabeth HospitalLouisville, KYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of UofL Health, which runs 7 hospitalsPatients rate it 2 of 5 · 66% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.26 (1.02 to 1.49), Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 227.99 (184.8 to 271.19) · 166 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 17.65 (13.37 to 21.93) · 1,251 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.471, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.443, Oct 2024 – Sep 2025
See every measure and the patient survey for Meritus Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 4 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.2 (11.5 to 17.6) · 314 cases | Worse | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.9 (1.6 to 2.3) · 630 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.268 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.207 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0.02 to 1.82) · 1,532 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.51 to 1.13) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.33 (115.95 to 226.71) · 89 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9 · 574 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 325 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 606 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 954 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.4 · 284 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,490 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 11,141 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.08 to 0.45) · 11,362 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.38 (1.41 to 5.35) · 1,735 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.45 (0 to 3.07) · 511 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.04 (1.59 to 4.49) · 1,665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.54 (1.6 to 15.49) · 483 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.04 (1.39 to 8.69) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.36 to 3.16) · 469 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.13 (0 to 0.73) · 9,894 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 34 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.445 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.364 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.268 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.026 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 245 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 639 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 24.7 · 260 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.3 · 690 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.4 · 992 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 952 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (4.1 to 7.6) · 314 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 671 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (10.6 to 18.8) · 421 cases | No different | Jan 2022 – Dec 2024 |
What patients said (531 patients answered, 17% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for University of Louisville Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 1 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 221.77 (180.78 to 262.76) · 121 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.362 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0.02 to 1.84) · 974 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.61 to 1.22) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 29 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.7 · 126 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 454 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 1,690 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,130 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 3,817 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.35 (2.42 to 6.27) · 1,361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.49 (0 to 3.12) · 483 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.79 to 3.59) · 1,416 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.55 (0 to 12.37) · 487 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.58 (0.28 to 6.88) · 474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.48 (0.07 to 2.88) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.83 (0.19 to 1.47) · 3,555 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.851 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.276 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.564 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.588 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 40 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 4.7 · 54 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 28.9 · 133 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 217 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.8 to 6.4) · 512 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (9.3 to 13.4) · 512 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.5 (10.8 to 19.5) · 316 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 257 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,237 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Uofl Health - Jewish Hospital and Mary & Elizabeth Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 4 the same, 1 worse of 7 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.26 (1.02 to 1.49) | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 227.99 (184.8 to 271.19) · 166 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 17.65 (13.37 to 21.93) · 1,251 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.471 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.443 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.29 (0.4 to 2.18) · 1,762 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 153 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.4 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 539 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.1 · 313 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 5,070 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.33 (0.15 to 0.52) · 8,172 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.05 to 0.42) · 8,926 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.69 (1.91 to 5.46) · 2,656 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0.25 to 2.97) · 1,171 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.49 (1.27 to 3.71) · 2,599 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.43 (4.61 to 10.24) · 1,190 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.03 (0.64 to 3.42) · 478 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 0.92) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 147 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.682 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.907 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.101 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 553 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 1,151 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.8 · 300 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 16.3 · 612 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33.1 · 564 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 1,132 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.1 · 146 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.6 · 260 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 467 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.6 (11.6 to 18.3) · 1,955 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.2) · 1,079 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,545 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 51% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$51,737
Medicare paid this office $51,737 for 488 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Occlusion of artery with review by radiologist | 18 | $7,008 | $350 |
| Destruction of growth of liver through skin using radiofrequency | 11 | $5,970 | $543 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 25 | $4,893 | $148 |
| X-ray of chest, 1 view | 256 | $2,248 | $6 |
| Drainage of fluid from abdominal cavity using imaging guidance | 20 | $1,845 | $71 |
See all 10 services
| Occlusion of artery with review by radiologist | 18 | $7,008 | $350 |
| Destruction of growth of liver through skin using radiofrequency | 11 | $5,970 | $543 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 25 | $4,893 | $148 |
| X-ray of chest, 1 view | 256 | $2,248 | $6 |
| Drainage of fluid from abdominal cavity using imaging guidance | 20 | $1,845 | $71 |
| Aspiration of fluid from chest cavity using imaging guidance | 17 | $1,808 | $82 |
| Ct guidance for tissue removal | 11 | $1,498 | $125 |
| Review by radiologist of abdominal artery image | 17 | $1,471 | $70 |
| X-ray of chest, 2 views | 77 | $567 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $145 | $9 |
Who their Medicare patients are
488 Original Medicare patients in 2024. Average age 71 · Under 65 16% · 85 and older 7% · Women 43% · Also on Medicaid 27% · Health risk score 2.54. Above the middle of the specialty; the typical interventional radiology clinician is at 2.27.
Conditions among them: High blood pressure 75% · Coronary heart disease 55% · Diabetes 53% · Chronic kidney disease 53% · Heart failure 51% · Atrial fibrillation 45% · COPD 41% · Depression 38% · Cancer 24% · Stroke 22% · Dementia 15%.
The office billed $656,615, Medicare allowed $65,540 and paid $51,737; for 822 services of 104 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 488 | 822 | 71 | 2.54 | $656,615 | $51,737 |
| 2023 | 348 | 596 | 70 | 2.53 | $542,243 | $44,353 |
| 2022 | 487 | 757 | 70 | 2.25 | $539,486 | $46,288 |
| 2021 | 218 | 482 | 68 | 2.99 | $592,633 | $52,655 |
| 2020 | 207 | 1,317 | 68 | 4.27 | $951,469 | $106,143 |
| 2019 | 110 | 444 | 67 | 5.03 | $1,310,824 | $51,728 |
| 2018 | 159 | 587 | 67 | 3.61 | $1,731,824 | $47,769 |
| 2017 | 167 | 607 | 64 | 3.42 | $2,223,349 | $61,224 |
| 2016 | 177 | 591 | 65 | 3.06 | $2,143,834 | $57,272 |
| 2015 | 169 | 707 | 66 | 3.16 | $2,316,293 | $79,695 |
| 2014 | 184 | 663 | 64 | 3.18 | $1,474,395 | $65,424 |
| 2013 | 143 | 624 | 64 | 3.29 | $1,568,899 | $67,856 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Occlusion of growths or obstructed vessels with review by radiologist | 15 | $7,221 | $425 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 17 | $3,857 | $143 |
| Review by radiologist of abdominal artery image | 17 | $1,794 | $72 |
| Drainage of fluid from abdominal cavity using imaging guidance | 18 | $1,313 | $69 |
| X-ray of chest, 1 view | 136 | $1,094 | $7 |
| X-ray of chest, 2 views | 62 | $444 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $316 | $10 |
| Limited ultrasound scan behind abdominal cavity | 11 | $213 | $19 |
2022: 10 services
| Insertion of central venous tube with port (5 years or older) | 11 | $2,790 | $254 |
| Drainage of fluid from abdominal cavity using imaging guidance | 18 | $1,776 | $68 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 20 | $1,754 | $84 |
| X-ray of chest, 1 view | 200 | $1,660 | $7 |
| Aspiration of fluid from chest cavity using imaging guidance | 16 | $1,443 | $85 |
| X-ray of chest, 2 views | 118 | $967 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $378 | $10 |
| Ultrasonic guidance for needle placement | 12 | $311 | $24 |
| Limited ultrasound scan behind abdominal cavity | 14 | $296 | $21 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 16 | $242 | $14 |
2021: 12 services
| Occlusion of growths or obstructed vessels with review by radiologist | 19 | $10,313 | $430 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 18 | $3,628 | $140 |
| Insertion of central venous tube with port (5 years or older) | 13 | $3,365 | $259 |
| Review by radiologist of abdominal artery image | 14 | $1,646 | $75 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 13 | $1,177 | $91 |
| Drainage of fluid from abdominal cavity using imaging guidance | 14 | $989 | $66 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $591 | $10 |
| Complete ultrasound scan behind abdominal cavity | 15 | $421 | $28 |
| Ultrasonic guidance for needle placement | 14 | $342 | $24 |
| Limited ultrasound scan of abdomen | 15 | $316 | $21 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 17 | $247 | $15 |
| Ultrasonic guidance for blood vessel access | 11 | $119 | $11 |
2020: 11 services
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 11 | $14,493 | $1,208 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 14 | $3,056 | $218 |
| Insertion of tube for infusion with imaging guidance and review by radiologist, patient 5 years or older | 13 | $853 | $66 |
| Review by radiologist of ct guidance for needle placement | 13 | $738 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $526 | $48 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 31 | $475 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 41 | $423 | $10 |
| Ultrasonic guidance for needle placement | 13 | $333 | $26 |
| Ultrasonic guidance for blood vessel access | 23 | $279 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 11 | $255 | $10 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 14 | $72 | $0 |
2019: 3 services
| Drainage of fluid from abdominal cavity using imaging guidance | 15 | $2,005 | $95 |
| Insertion of tube for infusion with imaging guidance and review by radiologist, patient 5 years or older | 20 | $1,563 | $74 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $330 | $11 |
2018: 11 services
| Occlusion of growths or obstructed vessels with review by radiologist | 12 | $8,356 | $492 |
| Insertion of tube for infusion (5 years or older) | 62 | $4,602 | $74 |
| Drainage of fluid from abdominal cavity using imaging guidance | 15 | $2,379 | $92 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 12 | $2,101 | $131 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 67 | $1,069 | $16 |
| Ultrasonic guidance for blood vessel access | 68 | $839 | $12 |
| Review by radiologist of abdominal artery image | 13 | $804 | $47 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 12 | $681 | $43 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 36 | $454 | $11 |
| Review by radiologist of additional artery image | 13 | $338 | $15 |
| Ultrasonic guidance for needle placement | 12 | $306 | $25 |
2017: 14 services
| Occlusion of growths or obstructed vessels with review by radiologist | 16 | $10,486 | $499 |
| Destruction of growth of liver through skin using radiofrequency | 12 | $9,240 | $660 |
| Insertion of tube for infusion (5 years or older) | 55 | $4,568 | $80 |
| Drainage of fluid from abdominal cavity using imaging guidance | 22 | $4,029 | $94 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 18 | $3,459 | $138 |
| Ct guidance for tissue removal | 12 | $2,342 | $167 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 67 | $1,142 | $16 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 18 | $1,076 | $43 |
| Review by radiologist of abdominal artery image | 16 | $1,068 | $46 |
| Needle biopsy of liver through skin | 14 | $1,034 | $74 |
| Ultrasonic guidance for blood vessel access | 71 | $926 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 55 | $686 | $11 |
| Ultrasonic guidance for needle placement | 18 | $500 | $28 |
| Review by radiologist of additional artery image | 17 | $376 | $15 |
2016: 10 services
| Occlusion of growths or obstructed vessels with review by radiologist | 13 | $7,640 | $509 |
| Insertion of tube for infusion (5 years or older) | 56 | $4,768 | $78 |
| Drainage of fluid from abdominal cavity using imaging guidance | 27 | $4,375 | $93 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 14 | $2,914 | $153 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 76 | $1,325 | $16 |
| Ultrasonic guidance for blood vessel access | 77 | $991 | $12 |
| Review by radiologist of abdominal artery image | 15 | $944 | $47 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 14 | $823 | $43 |
| Ultrasonic guidance for needle placement | 15 | $456 | $27 |
| Review by radiologist of additional artery image | 15 | $388 | $15 |
2015: 12 services
| Occlusion of growths or obstructed vessels with review by radiologist | 24 | $19,231 | $520 |
| Destruction of growth of liver through skin using radiofrequency | 11 | $8,871 | $682 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 23 | $5,210 | $141 |
| Insertion of tube for infusion (5 years or older) | 53 | $4,679 | $81 |
| Drainage of fluid from abdominal cavity using imaging guidance | 18 | $2,844 | $89 |
| Insertion of stomach tube using fluoroscopic guidance with contrast | 12 | $2,368 | $197 |
| Review by radiologist of abdominal artery image | 24 | $1,850 | $49 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 23 | $1,610 | $44 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 67 | $1,196 | $16 |
| Ultrasonic guidance for blood vessel access | 67 | $920 | $13 |
| Review by radiologist of additional artery image | 25 | $816 | $15 |
| Ultrasonic guidance for needle placement | 20 | $569 | $28 |
2014: 11 services
| Occlusion of growths or obstructed vessels with review by radiologist | 19 | $13,119 | $505 |
| Insertion of tube for infusion (5 years or older) | 64 | $5,403 | $79 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 21 | $4,519 | $151 |
| Drainage of fluid from abdominal cavity using imaging guidance | 23 | $2,972 | $93 |
| Review by radiologist of abdominal artery image | 21 | $1,442 | $48 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 20 | $1,351 | $45 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 72 | $1,308 | $16 |
| Ultrasonic guidance for blood vessel access | 74 | $1,066 | $13 |
| Review by radiologist of additional artery image | 20 | $724 | $15 |
| Ultrasonic guidance for needle placement | 20 | $547 | $27 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 11 | $393 | $36 |
2013: 10 services
| Insertion of catheter and device to stop blood flow or infusion to dissolve blood clot | 19 | $19,680 | $757 |
| Insertion of tube for infusion (5 years or older) | 54 | $4,418 | $78 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 12 | $2,470 | $137 |
| Imaging of blood vessel | 19 | $1,834 | $71 |
| Review by radiologist of image for insertion of material to block blood flow | 19 | $1,441 | $55 |
| Drainage of fluid from abdominal cavity using imaging guidance | 11 | $1,057 | $88 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 63 | $1,045 | $16 |
| Ultrasonic guidance for blood vessel access | 66 | $881 | $12 |
| Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | 12 | $783 | $43 |
| Ultrasonic guidance for needle placement | 18 | $501 | $28 |
Medicaid work
$2,292 in 2024
Medicaid paid $2,292 for 371 billed services this clinician did in 2024, up to 54 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Radiologic examination, chest; single view | 344 | $2,109 |
| Radiologic examination, chest; 2 views | 27 | $183 |
| 2024 | 371 | 2 | 54 | $2,292 |
| 2023 | 256 | 1 | 42 | $1,591 |
| 2022 | 495 | 2 | 72 | $2,764 |
| 2021 | 14 | 1 | 12 | $74 |
| 2020 | 37 | 1 | 16 | $659 |
| 2019 | 14 | 1 | 14 | $3,336 |
| 2018 | 261 | 4 | 28 | $19,910 |
See the largest Medicaid services in earlier years
2023
| Radiologic examination, chest; single view | 256 | $1,591 |
2022
| Radiologic examination, chest; single view | 404 | $2,210 |
| Radiologic examination, chest; 2 views | 91 | $553 |
2021
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 14 | $74 |
2020
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 37 | $659 |
2019
| Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, including all imaging guidance, image documentation, and all associated radiological supervision and interpretation required to perform the insertion; age 5 years or older | 14 | $3,336 |
2018
| INSERTION PICC W/O IMG GDN 5 YR/> | 53 | $13,815 |
| Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (List separately in addition to code for primary procedure) | 88 | $2,524 |
| FLUORO CENTRAL VENOUS ACCESS DEV PLACEMENT | 94 | $2,033 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 26 | $1,537 |
Drugs they prescribed that Part D paid
$293
Pharmacies billed $293 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 34% of their Part D prescriptions (18 of 53) in 2024. Above the middle of the specialty; the typical interventional radiology clinician is at 0%.
53 generic and 0 brand-name prescriptions · $293 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ondansetron | 19 | $109 | $6 |
| Methylprednisolone | 12 | $89 | $7 |
| Oxycodone | 18 | $76 | $4 |
Year by year
| 2024 | 53 | 22 | 34% (18) | 0% | $293 |
| 2023 | 11 | None | None | 0% | $58 |
| 2022 | 35 | 17 | 43% (15) | 0% | $289 |
| 2021 | 44 | 21 | 41% (18) | None | $283 |
| 2019 | 12 | None | None | 0% | $47 |
| 2017 | 35 | 22 | 91% (32) | 0% | $263 |
| 2016 | 31 | 19 | 84% (26) | 0% | $236 |
| 2015 | 34 | 19 | 68% (23) | 0% | $331 |
| 2014 | 29 | 19 | 83% (24) | 0% | $199 |
| 2013 | 19 | 11 | 84% (16) | None | $187 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Ondansetron | 13 | $165 | $13 |
| Oxycodone | 15 | $62 | $4 |
2021: 2 drugs
| Ondansetron | 14 | $107 | $8 |
| Oxycodone | 11 | $45 | $4 |
2017: 1 drug
| Oxycodone | 31 | $225 | $7 |
2016: 1 drug
| Oxycodone | 23 | $120 | $5 |
2015: 1 drug
| Oxycodone | 20 | $138 | $7 |
2014: 1 drug
| Oxycodone | 19 | $126 | $7 |
2013: 1 drug
| Oxycodone | 11 | $89 | $8 |
Money from drug and device companies
$486 in 2025
| 2025 | 4 | 5 | None | $486 |
| 2024 | 3 | 4 | None | $210 |
| 2023 | 3 | 5 | None | $511 |
| 2022 | 4 | 7 | $66 | $224 |
| 2021 | 4 | 14 | $192 | $336 |
| 2020 | 5 | 5 | $87 | $214 |
| 2019 | 6 | 6 | None | $453 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tepezza | $287 | 2 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $140 | 1 payment
|
| Boston Scientific | Embold Fibered | $31 | 1 payment
|
| Avanos Medical | Generator | $28 | 1 payment
|
See all 5 published payments
| Amgen | Meals · 2025-11-19 | None | $146 |
| Sirtex Medical | Meals · 2025-06-30 | Sir-Spheres Microspheres | $140 |
| Boston Scientific | Meals · 2025-06-23 | Embold Fibered | $31 |
| Avanos Medical | Meals · 2025-03-18 | Generator | $28 |
| Amgen | Meals · 2025-02-27 | Tepezza | $140 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $210
| Boston Scientific | Therasphere Y90 Glass Microspheres 10 Gbq | $112 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $82 | 2 payments
|
| AngioDynamics | Solero | $17 | 1 payment
|
2023: $511
| Sirtex Medical | Sir-Spheres Microspheres | $293 | 3 payments
|
| Inari Medical | Flowtriever Catheter, S | $200 | 1 payment
|
| Bard Peripheral Vascular | None | $18 | 1 payment
|
2022: $224
| Sirtex Medical | Sir-Spheres Microspheres | $115 | 1 payment
|
| Merit Medical Systems | Curved Needle | $66 | 4 payments
|
| Bard Peripheral Vascular | None | $25 | 1 payment
|
| Medtronic | Concertotm | $19 | 1 payment
|
2021: $336
| Merit Medical Systems | Curved Needle | $192 | 11 payments
|
| Silk Road Medical | Enhance Transcarotid Peripheral Access Kit | $105 | 1 payment
|
| Ge Healthcare | None | $22 | 1 payment
|
| Boston Scientific | Spyglass | $18 | 1 payment
|
2020: $214
| Merit Medical Systems | None | $87 | 1 payment
|
| Boston Scientific | General - Embolics | $76 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $25 | 1 payment
|
| Medtronic Vascular | Concerto | $15 | 1 payment
|
| Incyte | Jakafi | $12 | 1 payment
|
2019: $453
| Biocompatibles | Therasphere-Bio | $126 | 1 payment
|
| Surefire Medical | Precision Infusion System | $107 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $100 | 1 payment
|
| Varian Medical Systems | None | $67 | 1 payment
|
| Ekos | Ekosonic | $34 | 1 payment
|
| Boston Scientific | General Vascular Intervention | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 73.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1003871823
- Licence
- KY 53664, NJ 25MA066296600, NY 204291New Jersey 25MA06629600: Inactive
- Group
- University of Louisville Physicians Inc · Bowling Green-Warren County Community Hospital Corporation · Baptist Health Medical Group Inc · Meritus Medical Center Inc
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NY 01712376
- Taxonomy
- Federal specialty code 2085R0204X (2085R0204X); Diagnostic radiology (2085R0202X)
- Mailing address
- Po Box 909, Louisville, KY, 40201
- NPI first listed
- 2006-04-18
- NPI last updated
- 2025-07-07
- NPI record certified
- 2025-07-07
This is when the NPI record was last certified, not a medical board exam.